Finance

Lists
600223:SHA
Lushang Freda Pharmaceutical Co Ltd
CNÂ¥5.75
+0.70%
(+0.040) 1D
Aug 28, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600223...
Open
CNÂ¥5.72
High
CNÂ¥5.79
Low
CNÂ¥5.69
Mkt. cap
5.85B
Avg. vol.
9.78M
Volume
10.10M
Dividend
0.99%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jul 15, 2026
P/E ratio
36.18
52-wk high
CNÂ¥8.37
52-wk low
CNÂ¥4.89
EPS
CNÂ¥0.16
Shares outstanding
1.00B
No. of employees
4K
Open
CNÂ¥5.72
High
CNÂ¥5.79
Low
CNÂ¥5.69
Mkt. cap
5.85B
Avg. vol.
9.78M
Volume
10.10M
Dividend
0.99%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jul 15, 2026
P/E ratio
36.18
52-wk high
CNÂ¥8.37
52-wk low
CNÂ¥4.89
EPS
CNÂ¥0.16
Shares outstanding
1.00B
No. of employees
4K
About Lushang Freda Pharmaceutical Co Ltd
CEO-
Employees3.51K
FoundedApr 21, 1993
Headquarters-
SectorPersonal care products
Websitelshfreda.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
807.27M
1.05B
900.44M
1.01B
Cost of goods sold
405.63M
471.27M
396.42M
421.16M
Cost of revenue
405.63M
471.27M
396.42M
421.16M
Research and development expenses
36.89M
45.66M
36.86M
48.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
341.03M
474.78M
430.50M
473.99M
Operating expense
374.09M
533.36M
480.80M
517.29M
Total operating expenses
779.72M
1.00B
877.22M
938.45M
Operating income
27.55M
49.45M
23.22M
70.41M
Other non operating income
1.07M
-957.33K
-791.85K
-3.71M
EBT including unusual items
48.93M
82.80M
43.83M
72.63M
EBT excluding unusual items
57.55M
64.40M
43.79M
74.31M
Income tax expense
4.84M
23.67M
6.31M
8.27M
Effective tax rate
9.90%
28.59%
14.40%
11.39%
Other operating expenses
-7.23M
19.88M
5.68M
2.85M
Net income
33.78M
46.01M
31.90M
49.88M
Net profit margin
4.18%
4.36%
3.54%
4.94%
Earnings per share
-
-
-
-
Interest and investment income
29.41M
17.70M
21.99M
7.60M
Interest expense
-
-2.08M
-629.37K
-
Net interest expenses
29.41M
15.63M
21.36M
7.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
50.97M
75.36M
49.13M
97.21M
Gain or loss from assets sale
37.48K
55.90K
-
-78.27K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps